PMCB (PharmaCyte Biotech) Float Percentage Of Total Shares Outstanding: 94.42% (As of Jun. 28, 2026)


PMCB PharmaCyte Biotech Inc PMCB
32 GF Score
Price $0.75
! 2 Warning Signs
View Full Analysis

What is PharmaCyte Biotech Float Percentage Of Total Shares Outstanding?

PharmaCyte Biotech PMCB +1.44% 32 Float Percentage Of Total Shares Outstanding is 94.42% as of Jun. 28, 2026. GuruFocus rates PMCB with a GF Score™ of 32/100. The stock has 2 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, PharmaCyte Biotech's float shares is 10.14 Mil. PharmaCyte Biotech's total shares outstanding is 10.74 Mil. PharmaCyte Biotech's float percentage of total shares outstanding is 94.42%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, PharmaCyte Biotech's Insider Ownership is 11.97%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, PharmaCyte Biotech's Institutional Ownership is 9.71%.

PMCB
32GF Score
PharmaCyte Biotech Inc PMCB
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaCyte Biotech Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

PharmaCyte Biotech's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=10.14/10.74
=94.42%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 94.42% mean?
PharmaCyte Biotech (PMCB) has a Float Percentage Of Total Shares Outstanding of 94.42% as of Jun. 28, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on PharmaCyte Biotech and its competitors.
Is PharmaCyte Biotech's Float Percentage Of Total Shares Outstanding too high?
PharmaCyte Biotech's current Float Percentage Of Total Shares Outstanding is 94.42%. Overall, PharmaCyte Biotech has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does PharmaCyte Biotech's Float Percentage Of Total Shares Outstanding compare to IMNN and ACXP?
PharmaCyte Biotech's Float Percentage Of Total Shares Outstanding of 94.42% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on PharmaCyte Biotech and its competitors. PharmaCyte Biotech's current Float Percentage Of Total Shares Outstanding is 94.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCyte Biotech stock overvalued right now?
PharmaCyte Biotech (PMCB) has a current Float Percentage Of Total Shares Outstanding of 94.42%. The current Float Percentage Of Total Shares Outstanding is 94.42%. PharmaCyte Biotech's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For PharmaCyte Biotech (PMCB), the current Float Percentage Of Total Shares Outstanding is 94.42% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaCyte Biotech Business Description

Address 3960 Howard Hughes Parkway, Suite 500, Las Vegas, NV, USA, 89169
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
32GF Score

Get the complete analysis for PMCB

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.75
Price